These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15863659)

  • 1. BRCA1:185delAG found in the San Luis Valley probably originated in a Jewish founder.
    Makriyianni I; Hamel N; Ward S; Foulkes WD; Graw S
    J Med Genet; 2005 May; 42(5):e27. PubMed ID: 15863659
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of germline 185delAG BRCA1 mutations in non-Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado.
    Mullineaux LG; Castellano TM; Shaw J; Axell L; Wood ME; Diab S; Klein C; Sitarik M; Deffenbaugh AM; Graw SL
    Cancer; 2003 Aug; 98(3):597-602. PubMed ID: 12879478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of germline 185delAG BRCA1 mutations in non-Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado.
    Long HJ
    Cancer; 2004 Jan; 100(2):434-5. PubMed ID: 14716783
    [No Abstract]   [Full Text] [Related]  

  • 4. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
    Cierniková S; Tomka M; Kovác M; Stevurková V; Zajac V
    Neoplasma; 2006; 53(2):97-102. PubMed ID: 16575464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High incidence of BRCA1-2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma.
    Biron-Shental T; Drucker L; Altaras M; Bernheim J; Fishman A
    Eur J Surg Oncol; 2006 Dec; 32(10):1097-100. PubMed ID: 16650962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim.
    Bar-Sade RB; Kruglikova A; Modan B; Gak E; Hirsh-Yechezkel G; Theodor L; Novikov I; Gershoni-Baruch R; Risel S; Papa MZ; Ben-Baruch G; Friedman E
    Hum Mol Genet; 1998 May; 7(5):801-5. PubMed ID: 9536083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haplotype of the C61G BRCA1 mutation in Polish and Jewish individuals.
    Kaufman B; Laitman Y; Gronwald J; Lubinski J; Friedman E
    Genet Test Mol Biomarkers; 2009 Aug; 13(4):465-9. PubMed ID: 19594371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The BRCA1 Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in genome-wide case-control association studies.
    Pereira LH; Pineda MA; Rowe WH; Fonseca LR; Greene MH; Offit K; Ellis NA; Zhang J; Collins A; Struewing JP
    BMC Genet; 2007 Oct; 8():68. PubMed ID: 17916242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent origin of 185delAG BRCA1 mutation in an Indian family.
    Kadalmani K; Deepa S; Bagavathi S; Anishetty S; Thangaraj K; Gajalakshmi P
    Neoplasma; 2007; 54(1):51-6. PubMed ID: 17203892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant BRCA1 and BRCA2 gene mutations in an Ashkenazi Jewish woman with primary breast and ovarian cancer.
    Spannuth WA; Thaker PH; Sood AK
    Am J Obstet Gynecol; 2007 Apr; 196(4):e6-9. PubMed ID: 17403394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations.
    Laitman Y; Feng BJ; Zamir IM; Weitzel JN; Duncan P; Port D; Thirthagiri E; Teo SH; Evans G; Latif A; Newman WG; Gershoni-Baruch R; Zidan J; Shimon-Paluch S; Goldgar D; Friedman E
    Eur J Hum Genet; 2013 Feb; 21(2):212-6. PubMed ID: 22763381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Founder effect of the BRCA1 5382insC mutation in Brazilian patients with hereditary breast ovary cancer syndrome.
    da Costa EC; Vargas FR; Moreira AS; Lourenço JJ; Caleffi M; Ashton-Prolla P; Martins Moreira MA
    Cancer Genet Cytogenet; 2008 Jul; 184(1):62-6. PubMed ID: 18558292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1 disease-associated haplotypes in Singapore Malay women with early-onset breast/ovarian cancer.
    Ali AB; Iau PT; Putti TC; Sng JH
    Breast Cancer Res Treat; 2007 Sep; 104(3):351-3. PubMed ID: 17406974
    [No Abstract]   [Full Text] [Related]  

  • 14. BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland.
    Ratajska M; Brozek I; Senkus-Konefka E; Jassem J; Stepnowska M; Palomba G; Pisano M; Casula M; Palmieri G; Borg A; Limon J
    Oncol Rep; 2008 Jan; 19(1):263-8. PubMed ID: 18097605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic patent singles out Jewish women.
    Abbott A
    Nature; 2005 Jul; 436(7047):12. PubMed ID: 16001030
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic variation in IGF-1 and breast cancer risk in Ashkenazi carriers and noncarriers of BRCA1/2 mutations.
    Khoury-Shakour S; Lejbkowicz F; Barnett-Griness O; Tamir A; Pinchev M; Rennert G
    Eur J Cancer Prev; 2009 Sep; 18(5):361-7. PubMed ID: 19543094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A specific RAD51 haplotype increases breast cancer risk in Jewish non-Ashkenazi high-risk women.
    Gal I; Kimmel G; Gershoni-Baruch R; Papa MZ; Dagan E; Shamir R; Friedman E
    Eur J Cancer; 2006 May; 42(8):1129-34. PubMed ID: 16624550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil.
    Gomes MC; Costa MM; Borojevic R; Monteiro AN; Vieira R; Koifman S; Koifman RJ; Li S; Royer R; Zhang S; Narod SA
    Breast Cancer Res Treat; 2007 Jul; 103(3):349-53. PubMed ID: 17063270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of the BRCA1 del (exons 9-12) mutation in breast/ovarian cancer families outside of Mexican Hispanics.
    Torres D; Rashid MU; ; Seidel-Renkert A; Weitzel JN; Briceno I; Hamann U
    Breast Cancer Res Treat; 2009 Oct; 117(3):679-81. PubMed ID: 19333752
    [No Abstract]   [Full Text] [Related]  

  • 20. A common founder mutation of CERKL underlies autosomal recessive retinal degeneration with early macular involvement among Yemenite Jews.
    Auslender N; Sharon D; Abbasi AH; Garzozi HJ; Banin E; Ben-Yosef T
    Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5431-8. PubMed ID: 18055789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.